Details for New Drug Application (NDA): 214526
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 214526
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Taro |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 214526
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 214526
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | LOTION;TOPICAL | 214526 | ANDA | NORTHSTAR RX LLC | 16714-246 | 16714-246-01 | 1 BOTTLE in 1 CARTON (16714-246-01) / 60 mL in 1 BOTTLE |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | LOTION;TOPICAL | 214526 | ANDA | Taro Pharmaceuticals U.S.A., Inc. | 51672-1400 | 51672-1400-4 | 1 BOTTLE in 1 CARTON (51672-1400-4) / 60 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | LOTION;TOPICAL | Strength | EQ 1% BASE | ||||
Approval Date: | Jun 28, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription